Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A Virus-Induced Lung Inflammation
2011

Inhibition of Nox2 Oxidase Activity Ameliorates Influenza A Virus-Induced Lung Inflammation

Sample size: 6 publication Evidence: high

Author Information

Author(s): Vlahos Ross, Stambas John, Bozinovski Steven, Broughton Brad R. S., Drummond Grant R., Selemidis Stavros

Primary Institution: Department of Pharmacology, The University of Melbourne

Hypothesis

Is Nox2-containing NADPH oxidase a novel pharmacological target against lung inflammation caused by influenza A viruses?

Conclusion

Nox2 inhibitors have therapeutic potential for controlling lung inflammation and damage in an influenza strain-independent manner.

Supporting Evidence

  • Nox2−/y mice showed reduced lung inflammation and viral titers compared to WT mice.
  • In vivo administration of the Nox2 inhibitor apocynin significantly suppressed viral titer and airways inflammation.
  • Nox2 inhibitors could be considered for controlling lung inflammation caused by influenza A viruses.

Takeaway

This study shows that blocking a specific enzyme can help reduce lung damage caused by the flu virus, making it easier for the body to fight off the infection.

Methodology

Male WT and Nox2−/y mice were infected with influenza A virus, and various parameters including viral titer and lung inflammation were assessed.

Participant Demographics

Male C57BL/6 (wild type) and Nox2 deficient (Nox2−/y) mice aged between 7 and 10 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.1001271

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication